2022 saw Brassa win far more often than it didn’t, with 95% of its growth coming from new clients. The additions swelled a roster that now includes assignments from Organon (on its Jada system for postpartum hemorrhage control), Sage Therapeutics (for corporate communications) and Amneal Pharmaceuticals (for payer marketing across its portfolio). Brassa — the name is a mashup of the monikers of cofounders Brad Davis and Melissa Wildstein — anticipates more of the same in the back half of 2023 and is likely to staff up accordingly.
Click here to return to the MM+M Agency 100.
From the June 01, 2023 Issue of MM+M - Medical Marketing and Media
